ITRM940794A0 - "antagonisti di interleuchina -6(il-6) che consistono di forme solubili del ricettore & di il-6, mutate nell'interfaccia che si lega a gp 130". - Google Patents

"antagonisti di interleuchina -6(il-6) che consistono di forme solubili del ricettore & di il-6, mutate nell'interfaccia che si lega a gp 130".

Info

Publication number
ITRM940794A0
ITRM940794A0 ITRM940794A ITRM940794A ITRM940794A0 IT RM940794 A0 ITRM940794 A0 IT RM940794A0 IT RM940794 A ITRM940794 A IT RM940794A IT RM940794 A ITRM940794 A IT RM940794A IT RM940794 A0 ITRM940794 A0 IT RM940794A0
Authority
IT
Italy
Prior art keywords
interleukin
binds
receptor
interface
changed
Prior art date
Application number
ITRM940794A
Other languages
English (en)
Inventor
Gennaro Ciliberto
Carlo Toniatti
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Priority to ITRM940794A priority Critical patent/IT1274350B/it
Publication of ITRM940794A0 publication Critical patent/ITRM940794A0/it
Priority to EP95940401A priority patent/EP0742794A1/en
Priority to CN95191457A priority patent/CN1139933A/zh
Priority to CA002177837A priority patent/CA2177837A1/en
Priority to JP8517466A priority patent/JPH09503232A/ja
Priority to AU41866/96A priority patent/AU4186696A/en
Priority to PCT/IT1995/000208 priority patent/WO1996017869A2/en
Publication of ITRM940794A1 publication Critical patent/ITRM940794A1/it
Application granted granted Critical
Publication of IT1274350B publication Critical patent/IT1274350B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ITRM940794A 1994-12-06 1994-12-06 Antagonisti di interleuchina-6(il-6) che consistono di forme solubili del ricettore alfa di il-6, mutate nell'interfaccia che si lega a gp 130 IT1274350B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ITRM940794A IT1274350B (it) 1994-12-06 1994-12-06 Antagonisti di interleuchina-6(il-6) che consistono di forme solubili del ricettore alfa di il-6, mutate nell'interfaccia che si lega a gp 130
EP95940401A EP0742794A1 (en) 1994-12-06 1995-12-05 Interleukin-6 (il-6) antagonists
CN95191457A CN1139933A (zh) 1994-12-06 1995-12-05 由在GP130结合介面突变的白细胞介素-6(IL-6)受体α的可溶形式组成的IL-6拮抗剂
CA002177837A CA2177837A1 (en) 1994-12-06 1995-12-05 Interleukin-6 (il-6) antagonists
JP8517466A JPH09503232A (ja) 1994-12-06 1995-12-05 ＧＰ１３０結合界面で突然変異したインターロイキン−６（ＩＬ−６）受容体αの可溶性型であるＩＬ−６アンタゴニスト
AU41866/96A AU4186696A (en) 1994-12-06 1995-12-05 Interleukin-6 (il-6) antagonists
PCT/IT1995/000208 WO1996017869A2 (en) 1994-12-06 1995-12-05 Interleukin-6 (il-6) antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940794A IT1274350B (it) 1994-12-06 1994-12-06 Antagonisti di interleuchina-6(il-6) che consistono di forme solubili del ricettore alfa di il-6, mutate nell'interfaccia che si lega a gp 130

Publications (3)

Publication Number Publication Date
ITRM940794A0 true ITRM940794A0 (it) 1994-12-06
ITRM940794A1 ITRM940794A1 (it) 1996-06-06
IT1274350B IT1274350B (it) 1997-07-17

Family

ID=11402851

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM940794A IT1274350B (it) 1994-12-06 1994-12-06 Antagonisti di interleuchina-6(il-6) che consistono di forme solubili del ricettore alfa di il-6, mutate nell'interfaccia che si lega a gp 130

Country Status (7)

Country Link
EP (1) EP0742794A1 (it)
JP (1) JPH09503232A (it)
CN (1) CN1139933A (it)
AU (1) AU4186696A (it)
CA (1) CA2177837A1 (it)
IT (1) IT1274350B (it)
WO (1) WO1996017869A2 (it)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
PT852587E (pt) * 1995-09-28 2009-03-10 Yeda Res & Dev Péptidos sintéticos que inibem a actividade da il-6
US6217858B1 (en) * 1997-02-11 2001-04-17 Hadasit & Medical Research Services & Development Company, Ltd. Pharmaceutical composition for treating hepatitis B virus (HBV) infection
GB9621095D0 (en) * 1996-10-09 1996-11-27 Imperial College Novel system
AU736282B2 (en) 1997-03-21 2001-07-26 Chugai Seiyaku Kabushiki Kaisha A preventive or therapeutic agent for sensitized T cell- mediated diseases comprising IL-6 antagonist as an active ingredient
US7227837B1 (en) 1998-04-30 2007-06-05 At&T Labs, Inc. Fault tolerant virtual tandem switch
CA2237915A1 (en) 1998-05-19 1999-11-19 Stephen Shaughnessy Osteoporosis treatment
CA2341239C (en) 1998-08-24 2011-01-04 Chugai Seiyaku Kabushiki Kaisha A preventive or therapeutic agent for pancreatitis comprising il-6 antagonist as an active ingredient
JP4799516B2 (ja) * 1998-08-24 2011-10-26 中外製薬株式会社 Ｉｌ−６アンタゴニストを有効成分として含有する膵炎の予防又は治療剤
AU1345000A (en) * 1998-11-05 2000-05-22 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
WO2001016166A2 (en) 1999-08-27 2001-03-08 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Polypeptides, comprising il-6 ligand-binding receptor domains, and related nucleic acids, antibodies, compositions, and methods of use
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
AUPR769501A0 (en) * 2001-09-14 2001-10-11 Biomolecular Research Institute Limited Cytokine receptor 1
EP1607100A4 (en) 2003-02-24 2007-06-13 Chugai Pharmaceutical Co Ltd MEDICAMENT WITH AN INTERLEUKIN-6 ANTAGONIST FOR BACK-MARGIN INJURIES
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
MXPA06003768A (es) 2003-10-17 2006-06-23 Chugai Pharmaceutical Co Ltd Agente terapeutico para el mesotelioma.
AR048210A1 (es) 2003-12-19 2006-04-12 Chugai Pharmaceutical Co Ltd Un agente preventivo para la vasculitis.
US8470316B2 (en) 2005-10-14 2013-06-25 Chugai Seiyaku Kabushiki Kaisha Agents for suppressing damage to transplanted islets after islet transplantation
RU2450830C2 (ru) 2005-10-21 2012-05-20 Чугаи Сейяку Кабусики Кайся Средства для лечения кардиопатии
AR057582A1 (es) 2005-11-15 2007-12-05 Nat Hospital Organization Agentes para suprimir la induccion de linfocitos t citotoxicos
WO2007061029A1 (ja) 2005-11-25 2007-05-31 Keio University 前立腺癌治療剤
JP5033643B2 (ja) 2006-01-27 2012-09-26 学校法人慶應義塾 脈絡膜血管新生を伴う疾患の治療剤
JP5754875B2 (ja) 2006-04-07 2015-07-29 国立大学法人大阪大学 筋再生促進剤
MX2009007830A (es) 2007-01-23 2009-10-07 Univ Shinshu Inhibidor de rechazo cronico.
TW201503898A (zh) 2008-06-05 2015-02-01 Chugai Pharmaceutical Co Ltd 神經浸潤抑制劑
JP5904552B2 (ja) 2010-05-28 2016-04-13 国立研究開発法人国立がん研究センター 膵癌治療剤
RS63800B1 (sr) 2010-05-28 2022-12-30 Chugai Pharmaceutical Co Ltd Poboljšanje antitumorskog odgovora t ćelije
EP3009518B1 (en) 2013-06-11 2020-08-12 National Center of Neurology and Psychiatry Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (rrms) patient, and method for determining applicability of novel therapy
EP2898896A1 (en) 2014-01-22 2015-07-29 Université Pierre et Marie Curie (Paris 6) Agents for use in the treatment of retinal inflammation
TWI759261B (zh) 2015-02-27 2022-04-01 日商中外製藥股份有限公司 Ｉｌ－６受體抗體用於製備醫藥組成物的用途
EP3620531A4 (en) 2017-05-02 2021-03-17 National Center of Neurology and Psychiatry METHOD OF PREDICTION AND EVALUATION OF THERAPEUTIC EFFECT IN DISEASES RELATING TO IL-6 AND NEUTROPHILS
TWI822728B (zh) 2018-01-31 2023-11-21 加藤元一 含有il-6抑制劑的哮喘治療劑
CN112566650A (zh) * 2018-06-21 2021-03-26 沙塔克实验室有限公司 异二聚体蛋白及其用途
AU2020259884A1 (en) 2019-04-17 2021-10-07 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for urological cancer which is characterized by being administered with il-6 inhibitor and ccr2 inhibitor in combination
CN110133241B (zh) * 2019-05-21 2022-05-27 中国食品药品检定研究院 一种测定重组人可溶性gp130-Fc融合蛋白生物学活性的新方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3363463B2 (ja) * 1991-10-02 2003-01-08 忠三 岸本 Ｉｌ−６レセプター誘導体

Also Published As

Publication number Publication date
WO1996017869A3 (en) 1996-08-29
EP0742794A1 (en) 1996-11-20
AU4186696A (en) 1996-06-26
IT1274350B (it) 1997-07-17
WO1996017869A2 (en) 1996-06-13
ITRM940794A1 (it) 1996-06-06
JPH09503232A (ja) 1997-03-31
CN1139933A (zh) 1997-01-08
CA2177837A1 (en) 1996-06-07

Similar Documents

Publication Publication Date Title
IT1307900B1 (it) Antagonisti iii del recettore ccr-3.
MXPA03004439A (es) Aminotiazoles y su uso como antagonistas del receptor de adenosina.
ATE279517T1 (de) Il-17 receptor
ITMI941916A0 (it) Antagonisti recettoriali di il-1 ad aumentata attivita' inibitoria
FI922344L (fi) Muscarinreceptorantagonister.
FI922143A7 (fi) Muscarinreceptorantagonister.
IL156793A0 (en) 3,4-di-substituted cyclobutene-1,2-diones as cxc chemokine receptor antagonists
IT1308657B1 (it) Antagonisti ii del recettore ccr-3.
DE68914151D1 (de) Netzwerk-Sender-Empfänger.
TR199900318T2 (xx) IL-8 resept�r antagonistleri.
FI971026A7 (fi) Kinoksaliinidioni-NMDA-reseptoriantagonisteja
DE60231386D1 (de) Adenosin-a2a-rezeptor-antagonisten in kombination mit verbindungen mit neurotrophischer aktivität bei der behandlung von morbus parkinson
AP2002002605A0 (en) Il-8 receptor antagonists
FI916067L (fi) Receptor foer humant interleukin 5.
DE69232737D1 (de) Nukleotide sequenzen die für den murin-beta-3-adrenergischen rezeptor kodieren und ihre verwendungen
DE68925037D1 (de) Für den benutzer einstellbarer sessel.
WO2001064165A3 (en) Il-8 receptor antagonists
WO2000072800A3 (en) Il-8 receptor antagonists
EP0344979A3 (en) Alfa-adrenergic receptor antagonists
EP0344980A3 (en) Alpha-adrenergic receptor antagonists
DE69015745D1 (de) NMDA-Antagonisten.
DE69004455D1 (de) Alpha-adrenergene Rezeptor-Antagonisten.
IT1228978B (it) Perfezionamenti nell'ottenimento di cerotti.
ATE90098T1 (de) Cycloalkan(1,2-c:4,3-c'>dipyrazole.
DE69004827D1 (de) Alpha-adrenergene Rezeptor-Antagonisten.

Legal Events

Date Code Title Description
0001 Granted